24 results
8-K
EX-10.1
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes
8-K
EX-1.1
m4hg9mtz ix93824h
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-1.1
nw3b3oiql7umfpq
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
S-3
EX-1.2
wusfq 0fr2e
1 Jun 22
Shelf registration
4:06pm
DEF 14A
re82b
28 Apr 22
Definitive proxy
4:44pm
10-K
b64x3dky977k
7 Mar 22
Annual report
7:36am
10-Q
e5u07hgjqubmaosmwmz
10 Aug 21
Quarterly report
5:26pm
424B4
ervgk 2e6ijl88
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
EX-1.1
khjlez
24 May 21
IPO registration (amended)
6:16am